Global News Podcast Trump heads to China for crucial talks with Xi Jinping
26 snips
May 13, 2026 
Dr. Borodropulic, executive director of Caring Cross and CAR-T developer, explains a CAR-T style immunotherapy and study results. He breaks down how a single immune-cell infusion led to long HIV suppression. Short technical explanations and discussion of clinical trial outcomes keep the focus on this promising treatment.
AI Snips
Chapters
Transcript
Episode notes
Trump's Visit Focuses On Iran And Trade
- Donald Trump is visiting China to address two failing priorities: ending Iran's blockade of the Strait of Hormuz and repairing his diluted trade war with tariffs.
- Trump said he would have a "long talk" with Xi about Iran but insisted he didn't need China to end the conflict, framing the visit as diplomatic leverage.
Chongqing Shows China's Tech Strengths And Weaknesses
- Laura Bicker reports Chongqing showcases China's tech ambition but also deep economic strains like local government debt and uneven growth.
- The city exports cars globally and invests in robotics, yet older workers still do low-paid manual labor, highlighting uneven modernization.
Use CAR T Cells To Potentially Suppress HIV Long Term
- CAR T immune therapy reprograms patients' immune cells to find and destroy HIV-infected cells and protect CD4 cells, enabling some to stop antiretroviral drugs long-term.
- Early trial results show individuals suppressing HIV for up to nearly two years, and costs could fall from $350,000 to about $35,000 with process transfer.